Michael Ackermann

433 total citations
19 papers, 328 citations indexed

About

Michael Ackermann is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Ackermann has authored 19 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Ackermann's work include Plasma Applications and Diagnostics (3 papers), Immunotoxicology and immune responses (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Michael Ackermann is often cited by papers focused on Plasma Applications and Diagnostics (3 papers), Immunotoxicology and immune responses (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Michael Ackermann collaborates with scholars based in United States, Germany and Ireland. Michael Ackermann's co-authors include Michael I. Luster, Dori R. Germolec, Gary R. Burleson, D. Wallwiener, Sara Y. Brucker, Martin Weiß, Howard T. Hayes, Jakob Barz, Thomas A. Gasiewicz and Matthias B. Stope and has published in prestigious journals such as ACS Applied Materials & Interfaces, Environmental Health Perspectives and Kidney International.

In The Last Decade

Michael Ackermann

17 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ackermann United States 11 77 67 66 45 44 19 328
Kirsti Käpyaho Finland 14 92 1.2× 82 1.2× 298 4.5× 22 0.5× 43 1.0× 29 524
Douglas N. Cox United States 7 52 0.7× 88 1.3× 158 2.4× 46 1.0× 15 0.3× 10 455
Stephen P. Fitzgerald Germany 9 38 0.5× 45 0.7× 126 1.9× 45 1.0× 6 0.1× 16 366
Katja Benedikte Prestø Elgstøen Norway 15 55 0.7× 74 1.1× 237 3.6× 168 3.7× 17 0.4× 38 749
Patrick Neubert Germany 14 24 0.3× 93 1.4× 343 5.2× 53 1.2× 22 0.5× 26 611
Masaki Hirashima Japan 8 25 0.3× 75 1.1× 65 1.0× 49 1.1× 11 0.3× 15 368
Elizabeth L. Kramer United States 13 26 0.3× 149 2.2× 165 2.5× 13 0.3× 49 1.1× 28 573
Xin Shen China 12 71 0.9× 13 0.2× 53 0.8× 24 0.5× 21 0.5× 39 390
A D Hargreaves United Kingdom 9 41 0.5× 127 1.9× 182 2.8× 16 0.4× 8 0.2× 14 467
Taeko Hotta Japan 12 22 0.3× 32 0.5× 153 2.3× 17 0.4× 47 1.1× 46 469

Countries citing papers authored by Michael Ackermann

Since Specialization
Citations

This map shows the geographic impact of Michael Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ackermann more than expected).

Fields of papers citing papers by Michael Ackermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ackermann. The network helps show where Michael Ackermann may publish in the future.

Co-authorship network of co-authors of Michael Ackermann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ackermann. A scholar is included among the top collaborators of Michael Ackermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ackermann. Michael Ackermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Raskin, Joel, Anita H. Clayton, Susan G. Kornstein, et al.. (2025). A phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder. Current Medical Research and Opinion. 41(9). 1723–1734.
2.
Russo, Marc, Matthew Green, Bruce Mitchell, et al.. (2022). ID:16585 RCT: Ultra-Low-Frequency (ULF™) Waveform vs Traditional SCS in Temporary Trial for Nociceptive and Neuropathic Pain. Neuromodulation Technology at the Neural Interface. 25(5). S104–S104.
4.
Koch, André, Michael Ackermann, Jakob Barz, et al.. (2020). Cancer-Selective Treatment of Cancerous and Non-Cancerous Human Cervical Cell Models by a Non-Thermally Operated Electrosurgical Argon Plasma Device. Cancers. 12(4). 1037–1037. 27 indexed citations
5.
Weiß, Martin, Jakob Barz, Michael Ackermann, et al.. (2019). Dose-Dependent Tissue-Level Characterization of a Medical Atmospheric Pressure Argon Plasma Jet. ACS Applied Materials & Interfaces. 11(22). 19841–19853. 40 indexed citations
6.
Weiß, Martin, Michael Ackermann, Florin‐Andrei Taran, et al.. (2018). Characterization of a non‐thermally operated electrosurgical argon plasma source by electron spin resonance spectroscopy. Plasma Processes and Polymers. 16(2). 16 indexed citations
7.
Spraul, Manfred, Martin Hofmann, Michael Ackermann, et al.. (1997). Flow Injection Proton Nuclear Magnetic Resonance Spectroscopy Combined With Pattern Recognition Methods: Implications for Rapid Structural Studies and High Throughput Biochemical Screening. Analytical Communications. 34(11). 339–341. 36 indexed citations
8.
Ackermann, Michael, et al.. (1995). Endothelin Inhibits cAMP-Induced Renin Release from Isolated Renal Juxtaglomerular Cells. Journal of Cardiovascular Pharmacology. 26. S135–137. 15 indexed citations
9.
Krämer, Bernhard K., et al.. (1994). Endothelium-mediated regulation of renin secretion. Kidney International. 46(6). 1577–1579. 18 indexed citations
11.
Ackermann, Michael, et al.. (1989). Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 101(3). 470–480. 28 indexed citations
12.
Ackermann, Michael, et al.. (1989). Antitumor activity of murine neutrophils demonstrated by cytometric analysis.. PubMed. 49(3). 528–32. 21 indexed citations
13.
Luster, Michael I., Michael Ackermann, Dori R. Germolec, & Gary J. Rosenthal. (1989). Perturbations of the Immune System by Xenobiotics. Environmental Health Perspectives. 81. 157–157. 2 indexed citations
14.
Rosenthal, Gary J., Madeline Fort, Dori R. Germolec, et al.. (1989). Effect of Subchronic Arsine Inhalation on Immune Function and Host Resistance. Inhalation Toxicology. 1(2). 113–127. 2 indexed citations
15.
Germolec, Dori R., Raymond S. H. Yang, Michael Ackermann, et al.. (1989). Toxicology Studies of a Chemical Mixture of 25 Groundwater Contaminants. Toxicological Sciences. 13(3). 377–387. 5 indexed citations
16.
Ackermann, Michael & Page S. Morahan. (1988). Neutrophil involvement in effects of diethylstilbestrol and strontium 89 on macrophage activation by propionibacterium acnes. International Journal of Immunopharmacology. 10(1). 7–13. 5 indexed citations
17.
Rosenthal, Gary J., et al.. (1987). Comparative effects on the immune system of methotrexate and trimetrexate. International Journal of Immunopharmacology. 9(7). 793–801. 17 indexed citations
18.
Luster, Michael I., et al.. (1987). Selective immunosuppression in mice of natural killer cell activity by ochratoxin A.. PubMed. 47(9). 2259–63. 48 indexed citations
19.
Ackermann, Michael, R. Mark, Prasanta Chakraborty, & Page S. Morahan. (1986). Effects of Diethylstilbestrol on Propionibacterium acnes Immunomodulation: Inhibition of Macrophage Activation and Antitumor Activity. Journal of Leukocyte Biology. 40(5). 549–559. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026